beta2-integrins in demyelinating disease: not adhering to the paradigm.
about
Potential Coagulation Factor-Driven Pro-Inflammatory Responses in Ovarian Cancer Tissues Associated with Insufficient O₂ and Plasma Supply.LeukoCatch, a quick and efficient tool for the preparation of leukocyte extracts from blood.Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4.Th17 lymphocytes traffic to the central nervous system independently of α4 integrin expression during EAEPlatelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis.Discovery of novel disease-specific and membrane-associated candidate markers in a mouse model of multiple sclerosis.Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis.Signalling mechanisms of the leukocyte integrin αMβ2: current and future perspectives.Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.Leukotoxin kills rodent WBC by targeting leukocyte function associated antigen 1.CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria.A recombinant fusion protein derived from dog hookworm inhibits autoantibody-induced dermal-epidermal separation ex vivo.Glatiramer acetate treatment directly targets CD11b(+)Ly6G(-) monocytes and enhances the suppression of autoreactive T cells in experimental autoimmune encephalomyelitis.
P2860
Q33624680-7C274957-4AA8-46D8-B78A-E8A036620CE3Q33995081-78A1F4FB-D8B8-4726-864A-E022326D6DC0Q34975230-399C3C58-CCFB-47A8-B5EA-16BD143D76B4Q35669064-3D701EA3-9EC8-4FD4-80A0-27C450C14D57Q36055389-72746A8A-DD34-4BA2-9668-57B6C876A4C4Q37623616-C0B664FA-7813-4567-831E-F3C16F94C1B0Q37699549-D88B03D2-0E2B-48BF-8B78-974D247A4161Q38026930-ACF5837D-6029-4CE4-9322-19E9EA15535DQ38675620-3FD397EA-5A55-49E5-BBF4-F6E47D98EBA7Q39065493-EABA3426-E284-4748-8FEB-843B27E1B15DQ42401582-14470DE1-D566-45AC-AB3C-391329E39693Q43164477-315DF99C-DA66-43E1-95EC-7314145D2CCBQ46700855-C3B83A83-5508-4AD5-8F6C-0CFB02E6F0DFQ46858374-83824074-C09E-445A-8CD6-DE3F8AD8154F
P2860
beta2-integrins in demyelinating disease: not adhering to the paradigm.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@ast
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@en
type
label
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@ast
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@en
prefLabel
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@ast
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@en
P2093
P2860
P356
P1476
beta2-integrins in demyelinating disease: not adhering to the paradigm.
@en
P2093
Jillian E Wohler
Kari J Dugger
Scott R Barnum
Xianzhen Hu
P2860
P304
P356
10.1189/JLB.1009654
P577
2009-12-09T00:00:00Z